Search Results - "Klintmalm, E."

Limiting Hepatitis C Virus Progression in Liver Transplant Recipients Using Sirolimus‐Based Immunosuppression by McKenna, G. J., Trotter, J. F., Klintmalm, E., Onaca, N., Ruiz, R., Jennings, L. W., Neri, M., O’Leary, J. G., Davis, G. L., Levy, M. F., Goldstein, R. M., Klintmalm, G. B.

“…Hepatitis C virus (HCV) causes progressive liver fibrosis in liver transplant recipients and is the principal cause of long‐term allograft failure. The…”
Get full text

Sirolimus and cardiovascular disease risk in liver transplantation by McKenna, Greg J, Trotter, James F, Klintmalm, Erik, Ruiz, Richard, Onaca, Nicholas, Testa, Giuliano, Saracino, Giovanna, Levy, Marlon F, Goldstein, Robert M, Klintmalm, Goran B

“…Two adverse effects of sirolimus are hypertriglyceridemia and hypercholesterolemia. These elevated levels often lead clinicians to discontinue the sirolimus…”
Get full text

Long-Term Follow-Up of Liver Transplantation for Budd-Chiari Syndrome With Antithrombotic Therapy Based on the Etiology by CHINNAKOTLA, Srinath, KLINTMALM, Goran B, GOLDSTEIN, Robert M, STONE, Marvin J, KIM, Peter, TOMIYAMA, Koji, KLINTMALM, Erik, DAVIS, Gary L, TROTTER, James F, SAAD, Rana, LANDAVERDE, Carmen, LEVY, Marlon F

“…Because myeloproliferative disorders (MPDs) are a frequent cause of Budd-Chiari syndrome (BCS), treatment directed toward altering platelet production and…”
Get full text

THE SAFETY OF LATE CONVERSIONS TO SIROLIMUS IN LIVER TRANSPLANTATION: 2229 by McKenna, G. J., Trotter, J. F., Klintmalm, E., Chinnakotla, S., Ruiz, R., Onaca, N., Levy, M. F., Goldstein, R., Klintmalm, G.

Get full text

LIMITING HCV PROGRESSION IN TRANSPLANT RECIPIENTS THROUGH CONVERSION TO SIROLIMUS BASED IMMUNOSUPPRESSION: 2207 by McKenna, G. J., Trotter, J. F., Klintmalm, E., Chinnakotla, S., Onaca, N., Ruiz, R., Levy, M. F., Goldstein, R., Klintmalm, G.

Get full text